⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALVO News
Alvotech Ordinary Shares
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
globenewswire.com
ALVO
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alvotech (ALVO) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
ALVO
Investigation Alert: Alvotech (ALVO) Under Scrutiny - Contact Levi & Korsinsky For Details
accessnewswire.com
ALVO
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
globenewswire.com
ALVO
Alvotech kynnir afkomu fyrstu níu mánaða ársins og ræðir nýjustu áfanga í rekstri félagsins þann 13. nóvember nk.
globenewswire.com
ALVO
Alvotech Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm's Investigation
accessnewswire.com
ALVO
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
globenewswire.com
ALVO
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
globenewswire.com
ALVO
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
globenewswire.com
ALVO
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
globenewswire.com
ALVO